Dr Daryl Tan is a haematologist who was awarded the Singapore Government Human Manpower Development Plan (HMDP) fellowship to pursue postdoctoral training and clinical research in the field of lymphoma at Stanford University, USA. He is currently a board member of the Chapter of Haematologists and is appointed by the Ministry of Health as an advisor for the Residency Advisory Committee for Haematology training in Singapore. In 2011 Dr Tan helped set up a comprehensive haematology service and became the managing partner of the Raffles Cancer Centre and the Director of Research of Raffles Hospital. He integrated research with clinical practice, availing novel therapeutics for cancer patients failing standards of care.
Dr Tan continues to be an active practitioner while publishing research impacting the international community. His expertise in lymphoma and multiple myeloma was acknowledged by the publication of two lead-author review articles on their respective treatment guidelines in Lancet Oncology in 2014. His research has also led to numerous international presentations and more than 100 publications in high impact factor scientific journals including several first-authored articles in the Lancet Oncology, Blood and the Annals of Oncology.
Dr Tan served as the clinical lead for the lymphoma and multiple myeloma services at the Singapore General Hospital and spearheaded several clinical trials examining novel approaches in treating lymphoma and multiple myeloma. He was Assistant Professor at the Duke-NUS Graduate Medical School and received numerous grants from the National Medical Research Council, Singapore Health Foundation and the Singapore Cancer Syndicate for his research.